feed,title,long_url,short_url
Benzinga,"TC BioPharm Doses First 3 Patients in Phase 2b Clinical Trial of Lead Compound, OmnImmuneÂ®, To Treat Acute Myeloid Leukemia",https://benzinga.com/general/biotech/22/11/29826943/tc-biopharm-doses-first-3-patients-in-phase-2b-clinical-trial-of-lead-compound-omnimmune-to-treat,https://bit.ly/3gyG74l
Benzinga,"If You Invested $1000 In This Stock 15 Years Ago, You Would Have $4,900 Today",https://benzinga.com/news/earnings/22/11/29826910/if-you-invested-1000-in-this-stock-15-years-ago-you-would-have-4-900-today,https://bit.ly/3i7lhtd
Benzinga,$100 Invested In This Stock 15 Years Ago Would Be Worth $500 Today,https://benzinga.com/news/earnings/22/11/29826908/100-invested-in-this-stock-15-years-ago-would-be-worth-500-today,https://bit.ly/3gqdfeC
